A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control.

Circulation. Cardiovascular Quality and Outcomes
Barry L CarterCollaboration Among Pharmacists Physicians To Improve Outcomes Now (CAPTION) Trial Investigators

Abstract

Numerous studies have demonstrated the value of team-based care to improve blood pressure (BP) control, but there is limited information on whether these models would be adopted in diverse populations. The purpose of this study was to evaluate whether a collaborative model between physicians and pharmacists can improve BP control in multiple primary care medical offices with diverse geographic and patient characteristics and whether long-term BP control can be sustained. This study is a randomized prospective trial in 27 primary care offices first stratified by the percentage of underrepresented minorities and the level of clinical pharmacy services within the office. Each office is then randomized to either a 9- or 24-month intervention or a control group. Patients will be enrolled in this study until 2012. The results of this study should provide information on whether this model can be implemented in large numbers of diverse offices, if it is effective in diverse populations, and whether BP control can be sustained long term. URL: http://www.clinicaltrials.gov. Unique identifier: NCT00935077.

References

Apr 1, 1996·Journal of Clinical Epidemiology·A Donner, N Klar
Dec 31, 1998·The New England Journal of Medicine·D R BerlowitzM A Moskowitz
Jan 12, 2000·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·S J BillupsC D Sintek
Aug 25, 2001·The New England Journal of Medicine·D J Hyman, V N Pavlik
Jan 25, 2002·The British Journal of Social Psychology·C J Armitage, M Conner
Feb 28, 2002·Archives of Internal Medicine·Susan A OliveriaSteven M Asch
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Mar 11, 2004·JAMA : the Journal of the American Medical Association·Kevin Grumbach, Thomas Bodenheimer
Mar 18, 2006·Journal of Human Hypertension·J L MilchakC D Kreiter
Feb 3, 2007·The Journal of Clinical Hypertension·Gail ArderyYoonsang Kim
Mar 17, 2007·Journal of General Internal Medicine·Nancy R KressinDan R Berlowitz
Aug 22, 2007·Pharmacy World & Science : PWS·Shannon J Von MuensterYinghui Xu
Sep 26, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Lori M DickersonBarry L Carter
Nov 22, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Cheryl A Thompson
Nov 30, 2007·The Journal of Clinical Hypertension·Adam J RoseNancy R Kressin
Apr 11, 2008·The Journal of Clinical Hypertension·Barry L CarterArthur J Hartz
Jun 26, 2008·Pharmacotherapy·Jessica L MilchakUNKNOWN Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Nov 13, 2008·BMJ : British Medical Journal·Merrick ZwarensteinUNKNOWN Pragmatic Trials in Healthcare (Practihc) group
Oct 28, 2009·Archives of Internal Medicine·Barry L CarterPaul A James
Nov 26, 2009·Archives of Internal Medicine·Barry L CarterYinghui Xu

❮ Previous
Next ❯

Citations

Oct 13, 2010·Archives of Internal Medicine·Cynthia A WeberBarry L Carter
Feb 8, 2016·Journal of the American Society of Hypertension : JASH·Steven M SmithBarry L Carter
Feb 6, 2016·Research in Social & Administrative Pharmacy : RSAP·Inajara RottaFernando Fernandez-Llimos
Mar 20, 2013·Research in Social & Administrative Pharmacy : RSAP·David E DemikBarry L Carter
Dec 31, 2015·International Journal of Clinical Pharmacy·Tyler GumsEric Foster
May 9, 2015·Contemporary Clinical Trials·Barry L CarterLinnea A Polgreen
Mar 7, 2015·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Daisuke SonMiho Utsumi
Apr 26, 2013·The Journal of Clinical Hypertension·Ziqian ChenBarry L Carter
Jun 9, 2011·The Journal of Clinical Hypertension·Danielle M WentzlaffLucinda M Buys
Jun 5, 2013·The Journal of Clinical Hypertension·Barry L CarterUNKNOWN Collaboration Among Pharmacists and Physicians to Improve Outcomes Now (CAPTION) trial investigators
Aug 22, 2014·Pharmacotherapy·Tyler H GumsAngela Wisniewski
Jun 27, 2015·Pharmacotherapy·Barry L CarterUNKNOWN MEDication Focused Outpatient Care for Underutilization of Secondary Prevention Trial Investigators
Jun 17, 2015·Journal of the American Society of Hypertension : JASH·Tyler H GumsBarry L Carter
Aug 3, 2013·Evaluation & the Health Professions·Xiaofeng Steven Liu
Jan 20, 2018·Current Hypertension Reports·Korey A KenneltyBarry L Carter
Mar 26, 2015·Circulation. Cardiovascular Quality and Outcomes·Barry L CarterThomas Vaughn
Dec 21, 2016·Journal of the American Heart Association·Barry L Carter, Gail Ardery
Jun 10, 2018·Circulation. Cardiovascular Quality and Outcomes·Barry L CarterLinnea Polgreen
Mar 17, 2011·Circulation. Cardiovascular Quality and Outcomes·Harlan M Krumholz
Oct 20, 2018·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kristin D BradleyDeborah K Anderson
May 10, 2017·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Caitlin Dowd-GreenRosalyn W Stewart
Apr 5, 2018·Translational Behavioral Medicine·George A Mensah, Susan M Czajkowski
Jan 15, 2021·Contemporary Clinical Trials·Korey A KenneltyKathryn K Dorsey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.